Intravitreal therapeutic agents in noninfectious uveitic macular edema

about

Intravitreal therapeutic agents in noninfectious uveitic macular edema

Item

http://www.wikidata.org/entity/Q58806282

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@en

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@nl

type

Item

label

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@en

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@nl

prefLabel

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@en

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@nl

P1476

Intravitreal therapeutic agents in noninfectious uveitic macular edema

@en

P2093

Jyotirmay Biswas

http://www.w3.org/2001/XMLSchema#string

Kunal Kaushik Shah

http://www.w3.org/2001/XMLSchema#string

Parthopratim Dutta Majumder

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International

P2860

Management of noninfectious posterior uveitis with intravitreal drug therapy

Bevacizumab in inflammatory eye disease

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis.

Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion.

Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.

Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian Population.

Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion

P304

1060-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.4103/IJO.IJO_35_18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30038143

http://www.w3.org/2001/XMLSchema#string

P921

Chidenhi

macular retinal edema

uveitis

P932

6080427

http://www.w3.org/2001/XMLSchema#string